Dr. Gladys Onojobi, MD

Dr. Onojobi practices at Geisinger Medical Center Muncy in Muncy, Pennsylvania.

Dr. Onojobi's NPI, 1912944901, was assigned on May 31, 2006. Dr. Onojobi holds Maryland license D57378.

Dr. Onojobi's primary practice is Geisinger Medical Center Muncy, at 255 State Rte 220, Muncy, PA 17756 in Lycoming County. The practice phone is (570) 308-2600.

Dr. Onojobi's primary practice is Geisinger Medical Center Muncy in Muncy, Pennsylvania. Dr. Onojobi is also affiliated with Geisinger Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Onojobi to 4 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Onojobi practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Onojobi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Onojobi's licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 416 Medicare services from Dr. Onojobi across 2 procedure codes in 2024, all of them office visits, for 198 Medicare patients. Medicare paid $21,988 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 198 Medicare patients who saw Dr. Onojobi in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Onojobi's median patient age at 69, with 63% women.

In 2024, Dr. Onojobi wrote 571 Medicare Part D claims for 122 patients. 88% of them were for generic drugs. CMS names the drug for 436 of them, across 16 drugs with 11 or more claims each, at $493,512 in total drug cost. In 2023, CMS named 328 claims across 13 drugs.

Dr. Onojobi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Onojobi in 2014. 2014 was the busiest year, with 4. The most frequent topics are Anemia, Sickle Cell. Dr. Onojobi's most frequent co-authors are John Joseph Strouse, MD, Mary Catherine Beach, MD and Sophie Lanzkron, MD.

CMS Open Payments shows 345 general payments to Dr. Onojobi from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Bristol-Myers Squibb Company paid the most, $1,350.